150 related articles for article (PubMed ID: 29377165)
1. Pathophysiological mechanisms of autoimmunity.
Sudres M; Verdier J; Truffault F; Le Panse R; Berrih-Aknin S
Ann N Y Acad Sci; 2018 Feb; 1413(1):59-68. PubMed ID: 29377165
[TBL] [Abstract][Full Text] [Related]
2. Myasthenia Gravis: paradox versus paradigm in autoimmunity.
Berrih-Aknin S
J Autoimmun; 2014 Aug; 52():1-28. PubMed ID: 24934596
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and genetics of autoimmunity.
Theofilopoulos AN; Kono DH
Ann N Y Acad Sci; 1998 May; 841():225-35. PubMed ID: 9668244
[No Abstract] [Full Text] [Related]
4. Autoimmune mechanisms in myasthenia gravis.
Cavalcante P; Bernasconi P; Mantegazza R
Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
6. Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis.
Berrih-Aknin S; Ragheb S; Le Panse R; Lisak RP
Autoimmun Rev; 2013 Jul; 12(9):885-93. PubMed ID: 23537509
[TBL] [Abstract][Full Text] [Related]
7. Pathways leading to an immunological disease: systemic lupus erythematosus.
Zharkova O; Celhar T; Cravens PD; Satterthwaite AB; Fairhurst AM; Davis LS
Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i55-i66. PubMed ID: 28375453
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?
Cavalcante P; Barzago C; Baggi F; Antozzi C; Maggi L; Mantegazza R; Bernasconi P
Ann N Y Acad Sci; 2018 Feb; 1413(1):11-24. PubMed ID: 29363775
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
[TBL] [Abstract][Full Text] [Related]
10. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
Long H; Yin H; Wang L; Gershwin ME; Lu Q
J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.
Black LL; Srivastava R; Schoeb TR; Moore RD; Barnes S; Kabarowski JH
J Immunol; 2015 Nov; 195(10):4685-98. PubMed ID: 26466956
[TBL] [Abstract][Full Text] [Related]
12. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.
Morita K; Okamura T; Inoue M; Komai T; Teruya S; Iwasaki Y; Sumitomo S; Shoda H; Yamamoto K; Fujio K
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8131-E8140. PubMed ID: 27911796
[TBL] [Abstract][Full Text] [Related]
13. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.
Scheinecker C; Bonelli M; Smolen JS
J Autoimmun; 2010 Nov; 35(3):269-75. PubMed ID: 20638240
[TBL] [Abstract][Full Text] [Related]
14. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
15. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics.
Alahgholi-Hajibehzad M; Kasapoglu P; Jafari R; Rezaei N
Expert Rev Clin Immunol; 2015; 11(7):859-70. PubMed ID: 25973691
[TBL] [Abstract][Full Text] [Related]
16. Thymectomy and systemic lupus erythematosus (SLE).
Panarese A; D'Andrea V; Pironi D; Filippini A
Ann Ital Chir; 2014; 85(6):617-8. PubMed ID: 25919914
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of myasthenia gravis - a comprehensive review.
Avidan N; Le Panse R; Berrih-Aknin S; Miller A
J Autoimmun; 2014 Aug; 52():146-53. PubMed ID: 24361103
[TBL] [Abstract][Full Text] [Related]
18. IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity.
Domeier PP; Chodisetti SB; Soni C; Schell SL; Elias MJ; Wong EB; Cooper TK; Kitamura D; Rahman ZS
J Exp Med; 2016 May; 213(5):715-32. PubMed ID: 27069112
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells in systemic lupus erythematosus.
Ohl K; Tenbrock K
Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
[TBL] [Abstract][Full Text] [Related]
20. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
Ju ZL; Shi GY; Zuo JX; Zhang JW;
Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
